A detailed history of Seven Mile Advisory transactions in Astrazeneca PLC stock. As of the latest transaction made, Seven Mile Advisory holds 4,172 shares of AZN stock, worth $273,808. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,172
Previous 3,421 21.95%
Holding current value
$273,808
Previous $267 Million 21.83%
% of portfolio
0.22%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $57,579 - $65,802
751 Added 21.95%
4,172 $325 Million
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $25,254 - $30,553
378 Added 12.42%
3,421 $267 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $185,714 - $211,701
3,043 New
3,043 $206 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $14,072 - $15,558
217 Added 6.29%
3,665 $248 Million
Q2 2023

Aug 08, 2023

BUY
$69.91 - $75.81 $241,049 - $261,392
3,448 New
3,448 $247 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.